Common use of Grants to Licensee Clause in Contracts

Grants to Licensee. Subject to Section 2.2 and Section 4.7 and the other terms and conditions of this Agreement, Sanofi hereby grants to Licensee an exclusive (including with regard to Sanofi and its Affiliates) license (or sublicense), with the right to grant sublicenses in accordance with Section 2.3 or after Licensee complies with all of its obligations under Section 4.7, under the Licensed Patents and the Licensed Know-How to Exploit the Licensed Compound and Licensed Product in the Field in the Territory.

Grants to Licensee. Subject to Section 2.2 and Section 4.7 and the all other terms and conditions of this Agreement, Sanofi hereby grants to Licensee an exclusive (including with regard to Sanofi and its Affiliates) license sublicensable (or sublicense), with the right to grant sublicenses in accordance with Section 2.3 or after Licensee complies with all of its obligations under Section 4.7, (Sublicenses)) license under the Licensed Patents Patents, and to use the Licensed Know-How and the Other Data, in each case, to Exploit the Licensed Compound Compounds and the Licensed Product Products in the Field in the Territory.

Grants to Licensee. Subject to Section 2.2 and Section 4.7 and the all other terms and conditions of this Agreement, Sanofi hereby grants to Licensee an exclusive (including with regard to Sanofi and its Affiliates) license (or sublicense), with the right to grant sublicenses in accordance with Section 2.3 or after Licensee complies with all of its obligations under Section 4.7, under the Licensed Patents and to use the Licensed Know-How to Exploit the Licensed Compound Compounds and the Licensed Product Products in the Field in the Territory.

Grants to Licensee. Subject to Section 2.2 and Section 4.7 and the all other terms and conditions of this Agreement, Sanofi hereby grants to Licensee (a) an exclusive (including with regard to Sanofi and its Affiliates) license (or sublicense), with the right to grant sublicenses in accordance with Section 2.3 or after Licensee complies with all of its obligations under Section 4.7, under the Licensed Patents and to use the Licensed Know-How to Exploit the Licensed Compound and the Licensed Product Products in the Field in the Territory, and (b) a non-exclusive license to use the [***] to exploit Licensed Compound and Licensed Product solely with respect to Xxxxxxxxx’x Disease as its Indication in the Territory.